Discovering Glioma Tissue through Its Biomarkers' Detection in Blood by Raman Spectroscopy and Machine Learning

Study of the relationship among biomarkers, cell and tissue of glioma through Raman spectroscopy

Glioma is the most common brain tumors with high mortality and recurrence rates. Currently, the diagnosis methods for glioma are mainly based on tissue level, cellular level and biomarker level. In this paper, the characteristics of biomarkers (γ-aminobutyric acid and matrix mtalloproteinses-2), U87MG glioma cell and tissue were studied based on Raman spectroscopy, respectively. The results showed that the γ-aminobutyric acid concentration exhibited a linear relation with the intensity of characteristic peaks in 800-1600 cm-1 region, whereas the spectral baseline increased with the increasing of sample concentration in 200-700 cm-1 region. The Raman characteristics of matrix mtalloproteinses-2 in 20-1800 cm-1 region was investigated. Especially, it is demonstrated that the matrix mtalloproteinses-2 showed sixteen low-wavenumber Raman peaks in the range of 20-300 cm-1. Moreover, the U87MG glioma cell showed seven different Raman characteristic peaks in 600-1800 cm-1 region. Compared with the normal tissue, the Raman intensity of tumor tissue showed apparent intensity differences in 300-1800 cm-1, where the intensity changes of these Raman peaks were related to the reducing of the lipid metabolic pathways, and increase of the RNA in tumor tissue region. Furthermore, it is found that the Raman spectra of U87MG glioma cell and tumor tissue had corresponding peaks in the Raman spectra of the liquid γ-aminobutyric acid and matrix mtalloproteinses-2. It is suggested that the γ-aminobutyric acid and matrix mtalloproteinses-2 contributed to the formation and growth of glioma cell and tissue. Thus, Raman spectroscopy not only can diagnose glioma at the biomarkers, cellular and tissue level, but also analyze the relationship among the three. Furthermore, the results provided a physical marker for the detection of glioma in clinically.

Current research status of Raman spectroscopy in glioma detection

Glioma is the most common primary tumor of the nervous system. Conventional diagnostic methods for glioma often involve time-consuming or reliance on externally introduced materials. Consequently, there is an urgent need for rapid and reliable diagnostic techniques. Raman spectroscopy has emerged as a promising tool, offering rapid, accurate, and label-free analysis with high sensitivity and specificity in biomedical applications. In this review, the fundamental principles of Raman spectroscopy have been introduced, and then the progress of applying Raman spectroscopy in biomedical studies has been summarized, including the identification and typing of glioma. The challenges encountered in the clinical application of Raman spectroscopy for glioma have been discussed, and the prospects have also been envisioned.

Comment on "Raman spectroscopy combined with multivariate statistical algorithms for the simultaneous screening of cervical and breast cancers"

This article discusses current research on the detection of cervical and breast cancer using in vitro Raman spectral analysis of human serum by Cao et al. (2024) which was published in the Lasers in Medical Science journal. Despite the high accuracy of the suggested approach (93%), the demonstrated findings could be treated unclear due to possible overestimation of the classification models.

Performance of Classification Models of Toxins Based on Raman Spectroscopy Using Machine Learning Algorithms

Rapid and accurate detection of protein toxins is crucial for public health. The Raman spectra of several protein toxins, such as abrin, ricin, staphylococcal enterotoxin B (SEB), and bungarotoxin (BGT), have been studied. Multivariate scattering correction (MSC), Savitzky-Golay smoothing (SG), and wavelet transform methods (WT) were applied to preprocess Raman spectra. A principal component analysis (PCA) was used to extract spectral features, and the PCA score plots clustered four toxins with two other proteins. The k-means clustering results show that the spectra processed with MSC and MSC-SG methods have the best classification performance. Then, the two data types were classified using partial least squares discriminant analysis (PLS-DA) with an accuracy of 100%. The prediction results of the PCA and PLS-DA and the partial least squares regression model (PLSR) perform well for the fingerprint region spectra. The PLSR model demonstrates excellent classification and regression ability (accuracy = 100%, Rcv = 0.776). Four toxins were correctly classified with interference from two proteins. Classification models based on spectral feature extraction were established. This strategy shows excellent potential in toxin detection and public health protection. These models provide alternative paths for the development of rapid detection devices.